当前位置: X-MOL 学术Biomaterials › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Brain-targeted delivery shuttled by black phosphorus nanostructure to treat Parkinson's disease.
Biomaterials ( IF 14.0 ) Pub Date : 2020-08-23 , DOI: 10.1016/j.biomaterials.2020.120339
Sha Xiong 1 , Zhongjun Li 2 , Yao Liu 1 , Qun Wang 1 , Jingshan Luo 1 , Xiaojia Chen 3 , Zhongjian Xie 2 , Yuan Zhang 4 , Han Zhang 2 , Tongkai Chen 1
Affiliation  

The treatment of Parkinson's disease (PD) is hampered by the blood-brain barrier (BBB). As such, there is an urgent need for the development of a novel nanoplatform capable of penetrating the BBB in order to effectively treat PD. In the present study, we utilized black phosphorus nanosheets (BP) containing the brain-targeting ligand lactoferrin (Lf) and loaded with Paeoniflorin (Pae) to obtain Lf-BP-Pae. Through an effective photo-thermal effect, these Lf-BP-Pae particles were capable of traversing the BBB and effectively treating PD in a targeted manner. Importantly, this BP-based nanoplatform was capable of achieving satisfactory biocompatibility and biosafety with excellent anti-Parkinsonian efficacy, making it ideal for clinical applications.



中文翻译:

黑磷纳米结构穿梭于以脑为目标的传递,以治疗帕金森氏病。

帕金森氏病(PD)的治疗受到血脑屏障(BBB)的阻碍。因此,迫切需要开发能够穿透BBB以有效治疗PD的新型纳米平台。在本研究中,我们利用含有脑靶向配体乳铁蛋白(Lf)并负载Pa药苷(Pae)的黑磷纳米片(BP)来获得Lf-BP-Pae。通过有效的光热效应,这些Lf-BP-Pae颗粒能够穿过BBB并有针对性地有效治疗PD。重要的是,这种基于BP的纳米平台能够实现令人满意的生物相容性和生物安全性,同时具有出色的抗帕金森病功效,使其成为临床应用的理想选择。

更新日期:2020-08-27
down
wechat
bug